Cargando…
HIV Aspartyl Peptidase Inhibitors Interfere with Cellular Proliferation, Ultrastructure and Macrophage Infection of Leishmania amazonensis
BACKGROUND: Leishmania is the etiologic agent of leishmanisais, a protozoan disease whose pathogenic events are not well understood. Current therapy is suboptimal due to toxicity of the available therapeutic agents and the emergence of drug resistance. Compounding these problems is the increase in t...
Autores principales: | Santos, Lívia O., Marinho, Fernanda A., Altoé, Ellen F., Vitório, Bianca S., Alves, Carlos R., Britto, Constança, Motta, Maria Cristina M., Branquinha, Marta H., Santos, André L. S., d'Avila-Levy, Claudia M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656615/ https://www.ncbi.nlm.nih.gov/pubmed/19325703 http://dx.doi.org/10.1371/journal.pone.0004918 |
Ejemplares similares
-
Lopinavir, an HIV-1 peptidase inhibitor, induces alteration on the lipid metabolism of Leishmania amazonensis promastigotes
por: Rebello, Karina M., et al.
Publicado: (2018) -
Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients
por: Santos, Lívia O., et al.
Publicado: (2013) -
Docking simulation between HIV peptidase inhibitors and Trypanosoma cruzi aspartyl peptidase
por: Castilho, Vanessa V. S., et al.
Publicado: (2018) -
Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors
por: Sangenito, Leandro Stefano, et al.
Publicado: (2022) -
The Calpain Inhibitor MDL28170 Induces the Expression of Apoptotic Markers in Leishmania amazonensis Promastigotes
por: Marinho, Fernanda A., et al.
Publicado: (2014)